A Bernardo

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

L Biganzoli, F Puglisi, M Buyse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.